ArticlePLoS computational biology2026
Powerful large scale inference in high dimensional mediation analysis.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-dimensional causal mediation analysis by partial sum statistic and sample splitting strategy in imaging genetics application.Bioinformatics (Oxford, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In genome-wide epigenetic studies, determining how exposures (e.g., Single Nucleotide Polymorphisms) affect outcomes (e.g., gene expression) through intermediate variables, such as DNA methylation, is a key challenge. Mediation analysis provides a framework to identify these causal pathways; however, testing for mediation effects involves a complex composite null hypothesis. Existing methods, such as Sobel's test or the Max-P test, are often underpowered in this context because they rely on null distributions determined under only a subset of the null space and are not optimized for the multiple testing burden inherent in high-dimensional data. To address these limitations, we introduce MLFDR (Mediation Analysis using Local False Discovery Rates), a novel method for high-dimensional mediation analysis. MLFDR leverages local false discovery rates, calculated from the coefficients of structural equation models, to construct an optimal rejection region. We demonstrate theoretically and through simulation that MLFDR asymptotically controls the false discovery rate and achieves superior statistical power compared to recent high-dimensional mediation methods. In real data applications, MLFDR identified 20%-50% more significant mediators than existing methods, demonstrating its ability to uncover biological signals missed by conventional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.